Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
PUT
Restaurant Brands International
QSR
$25.8B
| $5.6M | ﹤0.01% |
84,000
| – | – |
|
1252
First Industrial Realty Trust
FR
$8.44B
| $5.58M | ﹤0.01% |
117,179
-7,113
| -6% | -$366K |
|
1253
Ironwood Pharmaceuticals
IRWD
$714M
| $5.57M | ﹤0.01% |
578,672
+123,874
| +27% | +$1.21M |
|
|
MRTX
1254
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.57M | ﹤0.01% |
127,774
+23,903
| +23% | +$853K |
|
|
LAZR
1255
DELISTED
Luminar Technologies
LAZR
| $5.56M | ﹤0.01% |
81,421
-5,866
| -7% | -$538K |
|
1256
Newell Brands
NWL
$2.56B
| $5.55M | ﹤0.01% |
614,222
-263,673
| -30% | -$2.62M |
|
1257
Teladoc Health
TDOC
$1.3B
| $5.54M | ﹤0.01% |
298,214
+18,317
| +7% | +$428K |
|
|
CPE
1258
DELISTED
Callon Petroleum Company
CPE
| $5.53M | ﹤0.01% |
141,484
+10,224
| +8% | +$378K |
|
1259
UGI
UGI
$7.33B
| $5.53M | ﹤0.01% |
240,621
+3,188
| +1% | +$79.1K |
|
1260
Rhythm Pharmaceuticals
RYTM
$7.96B
| $5.53M | ﹤0.01% |
241,261
+111,033
| +85% | +$2.49M |
|
1261
Plug Power
PLUG
$3.04B
| $5.53M | ﹤0.01% |
727,430
+149,588
| +26% | +$1.46M |
|
1262
Regal Rexnord
RRX
$11.9B
| $5.53M | ﹤0.01% |
38,677
-37,541
| -49% | -$5.78M |
|
1263
Flywire
FLYW
$2.16B
| $5.52M | ﹤0.01% |
173,122
+110,391
| +176% | +$3.53M |
|
|
LTHM
1264
DELISTED
Livent Corporation
LTHM
| $5.49M | ﹤0.01% |
298,253
+17,495
| +6% | +$400K |
|
1265
NNN REIT
NNN
$8.99B
| $5.48M | ﹤0.01% |
154,959
+31,924
| +26% | +$1.28M |
|
1266
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $5.47M | ﹤0.01% |
75,653
| – | – |
|
1267
Omega Healthcare
OHI
$14.7B
| $5.45M | ﹤0.01% |
164,416
-255,958
| -61% | -$8.18M |
|
1268
Westlake Corp
WLK
$9.9B
| $5.45M | ﹤0.01% |
43,693
-6,632
| -13% | -$851K |
|
1269
Zurn Elkay Water Solutions
ZWS
$8.53B
| $5.44M | ﹤0.01% |
194,322
-57,772
| -23% | -$1.65M |
|
1270
The Ensign Group
ENSG
$10.7B
| $5.44M | ﹤0.01% |
58,541
+7,209
| +14% | +$682K |
|
|
IMGN
1271
DELISTED
Immunogen Inc
IMGN
| $5.44M | ﹤0.01% |
342,727
+76,185
| +29% | +$1.27M |
|
1272
Chemed
CHE
$7.22B
| $5.43M | ﹤0.01% |
10,447
-942
| -8% | -$490K |
|
1273
First Interstate BancSystem
FIBK
$3.58B
| $5.43M | ﹤0.01% |
217,651
+2,721
| +1% | +$71K |
|
1274
CubeSmart
CUBE
$9.41B
| $5.42M | ﹤0.01% |
142,191
-18,067
| -11% | -$762K |
|
1275
Kymera Therapeutics
KYMR
$8.94B
| $5.41M | ﹤0.01% |
389,476
+4,493
| +1% | +$90.3K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.